2.68
price down icon4.29%   -0.12
after-market アフターアワーズ: 2.86 0.18 +6.72%
loading
前日終値:
$2.80
開ける:
$2.78
24時間の取引高:
719.45K
Relative Volume:
1.22
時価総額:
$165.14M
収益:
$40.37M
当期純損益:
$-119.72M
株価収益率:
-1.3136
EPS:
-2.0402
ネットキャッシュフロー:
$-135.06M
1週間 パフォーマンス:
-13.27%
1か月 パフォーマンス:
-22.99%
6か月 パフォーマンス:
-33.50%
1年 パフォーマンス:
-34.47%
1日の値動き範囲:
Value
$2.64
$2.79
1週間の範囲:
Value
$2.64
$3.165
52週間の値動き範囲:
Value
$2.64
$5.55

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Name
名前
Voyager Therapeutics Inc
Name
セクター
Healthcare (1067)
Name
電話
857-259-5340
Name
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Name
職員
141
Name
Twitter
@VoyagerTx
Name
次回の収益日
2026-11-09
Name
最新のSEC提出書
Name
VYGR's Discussions on Twitter

Compare VYGR vs VRTX, REGN, MRNA, ARGX, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VYGR icon
VYGR
Voyager Therapeutics Inc
2.68 165.14M 40.37M -119.72M -135.06M -2.0402
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
526.19 133.37B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
788.04 81.13B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
198.88 79.40B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
959.49 60.03B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
204.97 43.93B 742.00K -1.37B -1.07B -7.0731

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました Cantor Fitzgerald Overweight
2024-12-02 開始されました Citigroup Buy
2024-11-29 再開されました Wedbush Outperform
2024-10-16 開始されました Leerink Partners Outperform
2024-03-26 開始されました Guggenheim Buy
2024-03-19 開始されました H.C. Wainwright Buy
2024-03-07 開始されました Citigroup Buy
2024-01-02 アップグレード Wells Fargo Equal Weight → Overweight
2023-05-10 開始されました Truist Buy
2023-03-10 開始されました Oppenheimer Outperform
2021-10-07 アップグレード Robert W. Baird Neutral → Outperform
2021-02-26 ダウングレード Robert W. Baird Outperform → Neutral
2021-02-03 ダウングレード BTIG Research Buy → Neutral
2021-02-03 ダウングレード Wedbush Outperform → Neutral
2020-12-24 ダウングレード Cantor Fitzgerald Overweight → Neutral
2020-12-23 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-11 ダウングレード Oppenheimer Outperform → Perform
2020-11-10 ダウングレード Raymond James Strong Buy → Outperform
2020-11-10 ダウングレード Wells Fargo Overweight → Equal Weight
2020-03-19 開始されました The Benchmark Company Buy
2020-02-06 開始されました Oppenheimer Outperform
2018-11-15 アップグレード Raymond James Outperform → Strong Buy
2018-09-10 再開されました BTIG Research Buy
2018-09-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-06-04 開始されました H.C. Wainwright Buy
2018-03-12 ダウングレード Evercore ISI Outperform → In-line
2018-03-12 ダウングレード Wedbush Outperform → Neutral
2018-02-02 開始されました Morgan Stanley Overweight
2017-11-28 再開されました Piper Jaffray Overweight
2017-10-31 開始されました Robert W. Baird Outperform
2017-10-27 開始されました Canaccord Genuity Buy
2017-10-23 繰り返されました Stifel Buy
2017-10-12 開始されました Raymond James Outperform
2017-08-17 開始されました Evercore ISI Outperform
2017-07-28 再開されました Stifel Buy
すべてを表示

Voyager Therapeutics Inc (VYGR) 最新ニュース

pulisher
Sep 23, 2026

Live Voyager Therapeutics, Inc. (VYGR) Technical Analysis - Traders Union

Sep 23, 2026
pulisher
Sep 22, 2026

Voyager Therapeutics (VYGR) Receives a Rating Update from a Top Analyst - The Globe and Mail

Sep 22, 2026
pulisher
Sep 08, 2026

Voyager Therapeutics at wells fargo healthcare conference: key data ahead By Investing.com - Investing.com Nigeria

Sep 08, 2026
pulisher
Sep 08, 2026

Voyager Therapeutics at wells fargo healthcare conference: key data ahead - Investing.com

Sep 08, 2026
pulisher
Sep 05, 2026

Voyager Therapeutics stock holds steady as investors watch gene therapy pipeline - ad-hoc-news.de

Sep 05, 2026
pulisher
Sep 04, 2026

Voyager Therapeutics (VYGR) Rises 2.22% as Shares Hold Ground Between $3.29 Support and $3.63 ResistanceInsider Selling Alerts - dars.gov.et

Sep 04, 2026
pulisher
Sep 01, 2026

Voyager to Present at Upcoming Investor Conferences - markets.businessinsider.com

Sep 01, 2026
pulisher
Aug 31, 2026

Transcript : Voyager Therapeutics, Inc.Special Call - marketscreener.com

Aug 31, 2026
pulisher
Aug 28, 2026

Voyager Therapeutics Inc. (VYGR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026
pulisher
Aug 28, 2026

Voyager Therapeutics (VYGR) Rises 2.3% as Gene Therapy Stock Approaches Key Resistance at $3.72Composite Profile - siam.in

Aug 28, 2026
pulisher
Aug 27, 2026

Voyager Therapeutics Inc. (VYGR) Peer Comparison – Compare with Others - Value Research

Aug 27, 2026
pulisher
Aug 27, 2026

H.C. Wainwright reiterates Voyager Therapeutics stock rating at buy By Investing.com - Investing.com Nigeria

Aug 27, 2026
pulisher
Aug 27, 2026

H.C. Wainwright reiterates Voyager Therapeutics stock rating at buy - Investing.com

Aug 27, 2026
pulisher
Aug 21, 2026

Voyager Therapeutics (NASDAQ:VYGR) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat

Aug 21, 2026
pulisher
Aug 14, 2026

Voyager Therapeutics, Inc.: Financial Data Forecasts Estimates and Expectations | VT6 | US92915B1061 - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Armistice Capital (VYGR) files 13G/A showing 3.44M Voyager Therapeutics shares - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

Voyager to Advance 2 Tau-Targeted Alzheimer Therapies Toward Key Clinical Milestones - NeurologyLive

Aug 13, 2026
pulisher
Aug 13, 2026

Voyager’s New Alzheimer’s Trial Puts VYGR on Investors’ Early Watchlist - TipRanks

Aug 13, 2026
pulisher
Aug 13, 2026

CCORF Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Aug 13, 2026
pulisher
Aug 12, 2026

Analysts Have Just Cut Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Estimates By 47% - simplywall.st

Aug 12, 2026
pulisher
Aug 12, 2026

HC Wainwright Brokers Raise Earnings Estimates for VYGR - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR) and Teleflex (TFX) - The Globe and Mail

Aug 11, 2026
pulisher
Aug 10, 2026

Voyager Therapeutics (NASDAQ:VYGR) Earns Buy Rating from HC Wainwright - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

VYGR Reiterated by HC Wainwright & Co. -- Price Target Maintained at $25 - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - moomoo.com

Aug 10, 2026
pulisher
Aug 10, 2026

The Voyager Therapeutics, Inc. (NASDAQ:VYGR) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st

Aug 10, 2026
pulisher
Aug 08, 2026

Voyager Therapeutics (VYGR) Stock Rebounds While Cash Runway Concerns Persist - Sahm

Aug 08, 2026
pulisher
Aug 07, 2026

Voyager Therapeutics Inc earnings beat by $0.10, revenue fell short of estimates - Investing.com Nigeria

Aug 07, 2026
pulisher
Aug 07, 2026

Wedbush Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $8 - Moomoo

Aug 07, 2026
pulisher
Aug 07, 2026

Is Voyager Therapeutics Inc (VYGR) Overvalued After Q2 Earnings - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Voyager Reports Second Quarter 2026 Financial and Operating Results - The Manila Times

Aug 07, 2026
pulisher
Aug 07, 2026

Voyager Therapeutics (NASDAQ:VYGR) Issues Quarterly Earnings Results - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

VYGR Looks 86.3% Overvalued on GF Value™ - GuruFocus

Aug 06, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics: Q2 Earnings Snapshot - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics reports Q2 2026 net loss $24.5M, cash $148.8M; runway into 2028 - tradingview.com

Aug 06, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics (Nasdaq: VYGR) gains FDA IND clearance for VY1706 - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

VOYAGER THERAPEUTICS Q2 COLLABORATION REVENUE USD 3.165 MILLION - Moomoo

Aug 06, 2026
pulisher
Aug 06, 2026

Voyager Therapeutics (VYGR) Edges Higher by 1.45% as Shares Defend $2.99 SupportFibonacci Arc - dars.gov.et

Aug 06, 2026
pulisher
Jul 31, 2026

Voyager Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

Jul 31, 2026
pulisher
Jul 29, 2026

Voyager Therapeutics (VYGR) to Announce Quarterly Earnings on Wednesday - MarketBeat

Jul 29, 2026
pulisher
Jul 27, 2026

Voyager Therapeutics Inc (VYGR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

VYGR|Voyager Therapeutics Inc|Price:3.090|Chg%:-0.010 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Voyager Therapeutics Inc (VYGR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Voyager Therapeutics Inc (VYGR) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Voyager Therapeutics Inc (VYGR) Cash Flow - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

Voyager Therapeutics, Inc. Revenue Breakdown – NASDAQ:VYGR - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

Voyager Therapeutics Inc (VYGR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026

Voyager Therapeutics Inc (VYGR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$117.83
price down icon 3.06%
$35.80
price down icon 0.91%
$58.21
price down icon 0.14%
$255.96
price up icon 2.55%
ONC ONC
$360.85
price up icon 0.24%
$204.97
price up icon 2.56%
大文字化:     |  ボリューム (24 時間):